Andrographolide Inhibits Intimal Hyperplasia in a Rat Model of Autogenous Vein Grafts

Cell Biochemistry and Biophysics

Volumn 60, Issue 3, 2011, Pages 231-239

  Zhi Tao, Zhu ^a   Xue Song, Jiang ^a   Bai Chun, Wang ^a   Wei Xin, Meng ^a   Hong Yu, Liu ^a   Ye, Tian ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Andrographolide; Intimal hyperplasia; Vein grafting

Indexed keywords

ANDROGRAPHOLIDE; ANTIINFLAMMATORY AGENT; DITERPENE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GELATINASE B;

ANIMAL; ARTICLE; AUTOTRANSPLANTATION; CAROTID ARTERY; CORONARY ARTERY BYPASS GRAFT; DISEASE MODEL; FEMALE; GENETICS; HYPERPLASIA; INTIMA; JUGULAR VEIN; METABOLISM; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; TRANSPLANTATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CAROTID ARTERIES; CORONARY ARTERY BYPASS; DISEASE MODELS, ANIMAL; DITERPENES; E-SELECTIN; FEMALE; HYPERPLASIA; JUGULAR VEINS; MATRIX METALLOPROTEINASE 9; RATS; RATS, SPRAGUE-DAWLEY; TRANSPLANTATION, AUTOLOGOUS; TUNICA INTIMA;

ANIMALIA; RATTUS;

EID: 79958248833     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-010-9144-6     Document Type: Article

References (32)

1. Bourassa, M. G., Campeau, L., Lesperance, J., & Grondin, C. M. (1982). Changes in grafts and coronary arteries after saphenous vein aortocoronary bypass surgery: Results at repeat angiography. Circulation, 65, 90-97.
2. Rosenfeldt, F. L., Guo-Wei, H., Buxton, B. F., & Angus, J. A. (1999). Pharmacology of coronary artery bypass grafts. Annals of Thoracic Surgery, 67, 878-888.
3. Lie, J. T., Lawrie, G. M., & Morris, G. (1997). Aortocoronary bypass saphenous vein graft atherosclerosis. American Journal of Cardiology, 40, 907-914.
4. Atkinson, J. B., Forman, M. B., Vaughn, W. K., Robinowitz, M., Mcallister, H. A., & Virmani, R. (1985). Morphologic changes in long-term saphenous vein bypass grafts. Chest, 88, 341-348.
5. Habtemariam, S. (1998). Andrographolide inhibits the tumour necrosis factor-alpha-induced upregulation of ICAM-1 expression and endothelial-monocyte adhesion. Phytotherapy Research, 12, 37-40.
6. Chiou, W. F., Lin, J. J., & Chen, C. F. (1998). Andrographolide suppresses the expression of inducible nitric oxide synthase in macrophage and restores the vasoconstriction in rat aorta treated with lipopolysaccharide. British Journal of Pharmacology, 125, 327-334.
7. Chiou, W. F., Chen, C. F., & Lin, J. J. (2000). Mechanisms of suppression of inducible nitric oxide synthase (iNOS) expression in RAW 264. 7 cells by andrographolide. British Journal of Pharmacology, 129, 1553-1560.
8. Wang, T., Liu, B., Zhang, W., Wilson, B., & Hong, J. S. (2004). Andrographolide reduces inflammation-mediated dopaminergic neurodegeneration in mesencephalic neuron-glia cultures by inhibiting microglial activation. Journal of Pharmacology and Experimental Therapeutics, 308, 975-983.
9. Shen, Y. C., Chen, C. F., & Chiou, W. F. (2000). Suppression of rat neutrophil reactive oxygen species production and adhesion by the diterpenoid lactone andrographolide. Planta Medica, 66, 314-317.
10. Shen, Y. C., Chen, C. F., & Chiou, W. F. (2002). Andrographolide prevents oxygen radical production by human neutrophils: Possible mechanism(s) involved in its anti-inflammatory effect. British Journal of Pharmacology, 135, 399-406.
11. Lawrence, T., Gilroy, D. W., Colville-Nash, P. R., & Willoughby, D. A. (2001). Possible new role for NF-κB in the resolution of inflammation. Nature Medicine, 7, 1291-1297.
12. Yamamoto, Y., & Gaynor, R. B. (2001). Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. Journal of Clinical Investigation, 107, 135-142.
13. Gilmore, T. D. (2006). Introduction to NF-κB: Players, pathways, perspectives. Oncogene, 25, 6680-6684.
14. Perkins, N. D. (2007). Integrating cell signaling pathways with NF-κB and IKK function. Nature Reviews Molecular Cell Biology, 8, 49-62.
15. Pabst M. J. (1994). Priming of neutrophils. In P. G. Hellewell & T. J. Williams (Eds.), Immunopharmacology of neutrophils (pp. 195-221). London: Academic Press.
16. Albelda, S. M., Smith, C. W., & Ward, P. A. (1994). Adhesion molecules and inflammatory injury. FASEB J, 8, 504-512.
17. Xia, Y. F., Ye, B. Q., Li, Y. D., Wang, J. G., He, X. J., Lin, X., et al. (2004). Andrographolide attenuates inflammation by inhibition of NF-κB activation through covalent modification of reduced cysteine 62 of p50. Journal of Immunology, 173, 4207-4217.
18. Frenette, P. S., & Wagner, D. D. (1996). Adhesion molecules, I. New England Journal of Medicine, 334, 1526-1529.
19. Frenette, P. S., & Wagner, D. D. (1996). Adhesion molecules, II: Blood vessels and blood cells. New England Journal of Medicine, 335, 43-45.
20. Bevilacqua, M. P., Nelson, R. M., Mannori, G., & Cecconi, O. (1994). Endothelial-leukocyte adhesion molecules in human disease. Annual Review of Medicine, 45, 361-378.
21. Jiang, Y., Lincoff, A. M., Plow, E. F., & Topol, E. J. (1994). Cell adhesion molecules in coronary artery disease. Journal of the American College of Cardiology, 24, 1591-1601.
22. Jung, U., & Ley, K. (1997). Regulation of E-selectin, P-selectin, and intercellular adhesion molecule 1 expression in mouse cremaster muscle vasculature. Microcirculation, 4, 311-319.
23. Dewey, C. F., Jr, Bussolari, S. R., Gimbrone, M. A., Jr, & Davies, P. F. (1981). The dynamic response of vascular endothelial cells to fluid shear stress. Journal of Biomechanical Engineering, 103, 177-185.
24. Parks, W. C., & Shapiro, S. D. (2001). Matrix metalloproteinases in lung biology. Respiratory Research, 2, 10-19.
25. van den Steen, P. E., Dubois, B., Nelissen, I., Rudd, P. M., Dwek, R. A., & Opdenakker, G. (2002). Biochemistry and molecular biology of gelatinase B or matrix metalloproteinases-9 (MMP-9). Critical Reviews in Biochemistry and Molecular Biology, 37, 375-536.
26. Atkinson, J. J., & Senior, R. M. (2003). Matrix metalloproteinases-9 in lung remodeling. American Journal of Respiratory Cell and Molecular Biology, 28, 12-24.
27. Mason, D. P., Kenagy, R. D., Hasenstab, D., Bowen-Pope, D. F., Seifert, R. A., Coats, S., et al. (1999). Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circulation Research, 85, 1179-1185.
28. Lijnen, H. R., Soloway, P., & Collen, D. (1999). Tissue inhibitor of matrix metalloproteinases-1 impairs arterial neointima formation after vascular injury in mice. Circulation Research, 85, 1186-1191.
29. Bond, M., Baker, A. H., & Newby, A. C. (1999). Nuclear factor-κB activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts. Biochemical and Biophysical Research Communications, 264, 561-567.
30. Bond, M., Chase, A. J., Baker, A. H., & Newby, A. C. (2001). Inhibition of transcription factor NF-kappa B reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovascular Research, 50, 556-565.
31. Saren, P., Welgus, H. G., & Kovanen, P. T. (1996). TNF-α and IL-1β selectively induce expression of 92-kDa gelatinase by human macrophages. Journal of Immunology, 157, 4159-4165.
32. Galt, S. W., Lindemann, S., Medd, D., Allen, L. L., Kraiss, L. W., Harris, E. S., et al. (2001). Differential regulation of matrix metalloproteinase-9 by monocytes adherent to collagen and platelets. Circulation Research, 89, 509-516.